Consistently with its oncogenic role and regulation mechanism on chemokines in vitro, BCAT2 deficiency inhibited tumor growth and prolonged survival time in vivo, by upregulating CD8+T related chemokines (Figure 6B–E; Figure S20A, Supporting Information). This evidence concerns the gene CD8A and neoplasm.